Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis

Area of Science:

• Neuroimmunology
• Immunology
• Genetics

Background:

• Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for studying demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis (MS).
• Apolipoprotein E (apoE) is a lipid-binding protein involved in lipid metabolism and transport, and has been implicated in neuroinflammation and neuroprotection.

Purpose of the Study:

• To investigate the role of apolipoprotein E (apoE) in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) in female mice.
• To determine the impact of apoE deficiency on disease course, immune responses, and CNS pathology in EAE.

Main Methods:

• Induction of EAE in female apolipoprotein-E (apoE) deficient mice and wild-type control mice.
• Monitoring of clinical disease scores, incidence, and mortality.
• Assessment of lymphocyte proliferation responses to myelin antigens and mitogens.
• Histopathological analysis of central nervous system (CNS) tissue for inflammatory lesions.

Main Results:

• Apolipoprotein-E (apoE) deficient female mice exhibited a significantly chronic and worse course of EAE compared to controls.
• EAE incidence (64% vs 31%), maximal clinical score (2.81 vs 0.75), and mortality (27.3% vs 0%) were significantly higher in apoE deficient mice.
• Increased lymphocyte proliferation and more CNS infiltrating lesions were observed in apoE deficient mice.

Conclusions:

• Apolipoprotein E (apoE) deficiency exacerbates experimental autoimmune encephalomyelitis (EAE) in female mice.
• Enhanced immune reactivity and potentially defective neuronal repair mechanisms in apoE deficient mice may contribute to disease severity.
• These findings suggest a potential role for apoE in modulating neuroinflammation and disease progression relevant to multiple sclerosis (MS).